Revenue for the first nine months of 2024: €6.4 million, a 11% increase compared to the same period last year First delivery of Olea equipment worth €0.5 million completed in the United States...
Spine tech innovators elliquence and Implanet to exhibit at NASS in Chicago, September 25-28, 2024 (elliquence LLC Booth 2419 Implanet Booth 2412) Regulatory News: elliquence LLC, specializing...
Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of...
Regulatory News: IMPLANET (Euronext Growth : ALIMP, FR0013470168, éligible au PEA-PME), société de technologies médicales spécialisée dans les implants destinés à la chirurgie orthopédique et...
Revenue of €4.1 million in the first half of 2024 Sales force investment aimed at revitalizing the Company’s presence in the United States Strict management of operational expenses, including...
Poursuite de la dynamique de croissance enregistrée sur le marché français Solide progression des ventes d’équipements médicaux, +81% vs. S1 2023 Regulatory News: IMPLANET (Euronext Growth :...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.008 | 7.04845814978 | 0.1135 | 0.146 | 0.113 | 299997 | 0.12675136 | DE |
4 | 0.0075 | 6.57894736842 | 0.114 | 0.146 | 0.103 | 207264 | 0.11879107 | DE |
12 | 0.018 | 17.3913043478 | 0.1035 | 0.146 | 0.085 | 167637 | 0.11133899 | DE |
26 | 0.0465 | 62 | 0.075 | 0.1675 | 0.07 | 256097 | 0.11274505 | DE |
52 | 0.0683 | 128.383458647 | 0.0532 | 0.1675 | 0.035 | 250314 | 0.09752464 | DE |
156 | -0.4585 | -79.0517241379 | 0.58 | 0.658 | 0.035 | 207557 | 0.19575476 | DE |
260 | 0.0496 | 68.9847009736 | 0.0719 | 3.38 | 0.035 | 200735 | 0.316465 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales